Scalpel Weekly News

Week of: February 04, 2013

IN THE NEWS


Risk of Irreversible Potentially Fatal Liver Injury From Use of SAMSCA (Tolvaptan)

The FDA along with the manufacturer, Otsuka, notified healthcare professionals of significant liver injury associated with the use of Samsca.  Click title to continue reading...


 
MEDICAL ALERTS


CDC Releases Information on Dietary Sodium Reduction Including 50-State Survey of Laws and Policies that Support Reduction of Sodium in Food Supply

To support Americans' New Year's health and nutrition goals and in advance of American Heart Month, the CDC’s Public Health Law Program (PHLP) has released a series of legal resources on dietary sodium reduction. Click title to continue reading...



FDA Approves Over-the-Counter Oxytrol for Women to Treat Overactive Bladder

The FDA approved Oxytrol for Women, the first over-the-counter treatment for overactive bladder in women ages 18 years and older. Click title to continue reading...



FDA Approves Three New Drug Treatments for Type 2 Diabetes

The FDA approved three new related products for use with diet and exercise to improve blood sugar control in adults with type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin and metformin hydrochloride) tablets, and Oseni (alogliptin and pioglitazone) tablets. Click title to continue reading...


  CASE ALERTS


California’s Cost-Shifting Offer of Compromise Does Not Require Standard Form, Allows Separate Acceptance and Reasonable Offers with Some Discovery

A man under medical care died. His wife and daughters filed wrongful death and medical negligence claims against his doctor. Click title to continue reading...



Kansas 50 Percent Practice Rule for Expert Witnesses Requires Evaluation of All Clinical Practice Including Varied Patient Care Activities

A woman suffered from idiopathic subglottic tracheal stenosis, a narrowing of the trachea below the vocal chords that causes difficulty in breathing. One doctor tried to alleviate the woman’s breathing difficulty by surgically implanting two metal stents in her trachea. Click title to continue reading...



Nursing Home’s Optional Arbitration Agreement Not Health Care Decision for Health Care Surrogate Under West Virginia Health Care Decisions Act

A woman suffering from Alzheimer’s disease and dementia had a designated health care surrogate pursuant to West Virginia’s Health Care Decisions Act. Among the paperwork to be signed upon the woman’s admission to a nursing home was an arbitration agreement. Click title to continue reading...